AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 161 min read$ICHR

MacKenzie Iain sold $1.0M of ICHR

MacKenzie Iain sold 20,000 shares of ICHOR HOLDINGS, LTD. (ICHR) at an average of $50.66 ($50.52–$51.59, $1.01M total) across 2 trades on 2026-09-15 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · MacKenzie Iain
Published Sep 16, 2026, 8:16 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 16, 2026, 8:22 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$ICHR
Neutral
medium confidence
Mentioned
$ICHR
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ICHRNeutralLow
01

Why it matters

Routine insider transaction with modest dollar amount; unlikely to drive significant price movement.

02

Market read

Provides a factual update on insider holdings; limited trading relevance.

03

What to watch

Potential upcoming clinical data releases could make the sale timing coincidental.

Relevance 5/10Novelty 4/10Timing: post‑market 2026‑09‑15

Background

Form 4 filing from SEC EDGAR reporting a director's stock sale under a 10b5‑1 plan.

Company-level read

Ticker impact

$ICHRNeutralMedium confidence
Context

Director MacKenzie Iain sold 20,000 shares for $1.0M via a 10b5‑1 plan, reducing his stake to 102,427 shares.

Expected impact

Potential slight downward pressure, likely limited to short‑term volatility.

Evidence & confidence

Sale amount is under $2M and follows a pre‑arranged plan, typical for liquidity needs; no immediate catalyst.

Market effects

Sector

Minimal impact on biotech sector; similar insider sales are common.

Regional

No broader regional effect.

Global

Limited relevance; only affects ICHR shareholders.

Counterpoint

What could challenge this read

Sale could be unrelated to company outlook; may simply be personal liquidity.

Key entities

  • company
    ICHR

    Ichor Holdings, Ltd., a biotech listed on NASDAQ.

  • person
    MacKenzie Iain

    Director of Ichor Holdings.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

ICHR insider trading history →

Related articles

AUG 5
$ICHRMedAI 8/10

Ichor Holdings, Ltd. Q2 2026 Earnings Call Summary

Ichor Holdings reported Q2 2026 revenue up 15% sequentially, with gross margin rising 130 bps to 14.1%. Management attributed a Q2 revenue shortfall to brief flow-control part shortages resolved after quarter end, shifting volume to Q3. It expects sequential revenue growth above 10% for the next two quarters and full-year 2026 revenue up at least 30% vs 2025, with gross margin gains of 100 bps per quarter. An ATM raised $195m net proceeds.

yahoo.com7 min
AUG 3
$ICHRMed

Why is Ichor Holdings stock sliding today?

Ichor Holdings (ICHR) shares fell 12.9% in after-hours after its Q2 2026 results. The company reported adjusted EPS of $0.34 on revenue of $294.8M, beating consensus, with gross margin at 14.1%. Operating cash flow was -$15.9M and it completed a $200M at-the-market offering. Q3 revenue guidance was $315M-$345M.

investing.com4 min
AUG 3
$PLTRMed

After-Hours Stock Movers: PLTR, SNAP, ON, ICHR, WGS, WHR

Investing.com’s after-hours movers report highlights Palantir (PLTR) up 10% after Q2 EPS of $0.41 and $1.94B revenue, with 2026 revenue guidance raised to $8.15–$8.158B. Snap (SNAP) rose 9.6% on Q2 revenue $1.6B and Q3 guidance $1.7–$1.74B. Backblaze (BLZE) gained 16% on Q2 beat and raised 2026 revenue to $172–$174M. ON (ON) +5%, ICHR -11%, WGS -7%, WHR -4%.

investing.com6 min
MAY 27
$ICHRMedAI 9/10

Ichor Holdings, Ltd. $ICHR Shares Bought by Royce & Associates LP

Royce & Associates LP increased its Ichor Holdings (NASDAQ:ICHR) stake by 48.5% in Q4 to 1,449,082 shares, worth $26.71M, after buying 473,440 shares, according to SEC filings cited by HoldingsChannel. Other institutions also added shares. CEO Philip Ryan Sr. Barros sold 21,000 shares at $46.63. Analysts raised price targets; consensus average is $64.57.

tickerreport.com3 min